About the Authors
- Tania Fleitas
-
* E-mail: tfleitask@gmail.com
Affiliation Department of Medical Oncology, Hospital Universitario y Politécnico La Fe Valencia, Valencia, Spain
- Vicenta Martínez-Sales
-
Affiliation Research Center,Hospital Universitario y Politécnico La Fe Valencia, Valencia, Spain
- Virtudes Vila
-
Affiliation Research Center,Hospital Universitario y Politécnico La Fe Valencia, Valencia, Spain
- Edelmiro Reganon
-
Affiliation Research Center,Hospital Universitario y Politécnico La Fe Valencia, Valencia, Spain
- David Mesado
-
Affiliation Research Center,Hospital Universitario y Politécnico La Fe Valencia, Valencia, Spain
- Maria Martín
-
Affiliation Department of Medical Oncology, Hospital Universitario y Politécnico La Fe Valencia, Valencia, Spain
- José Gómez-Codina
-
Affiliation Department of Medical Oncology, Hospital Universitario y Politécnico La Fe Valencia, Valencia, Spain
- Joaquín Montalar
-
Affiliation Department of Medical Oncology, Hospital Universitario y Politécnico La Fe Valencia, Valencia, Spain
- Gaspar Reynés
-
Affiliation Department of Medical Oncology, Hospital Universitario y Politécnico La Fe Valencia, Valencia, Spain
Competing Interests
The following industries: Roche Pharma, Amgen, Lilly, MSD, and Bayer contributed financially to the purchase of reagents and for hiring a laboratory technician, in accordance with legal procedure of the foundation of Hospital La Fe for donations,without any kind of interest in the results of the study, and they did not participated in any other aspect in the study.This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: TF VMS VV GR. Performed the experiments: TF VMS VV DM. Analyzed the data: TF VMS VV ER GR. Contributed reagents/materials/analysis tools: TF VMS VV JGC JM GR. Wrote the paper: TF VMS VV MM GR.